CA1203176A - Produits pharmaceutiques - Google Patents

Produits pharmaceutiques

Info

Publication number
CA1203176A
CA1203176A CA000429095A CA429095A CA1203176A CA 1203176 A CA1203176 A CA 1203176A CA 000429095 A CA000429095 A CA 000429095A CA 429095 A CA429095 A CA 429095A CA 1203176 A CA1203176 A CA 1203176A
Authority
CA
Canada
Prior art keywords
cellulose
pharmaceutical composition
salbutamol
physiologically acceptable
acceptable salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000429095A
Other languages
English (en)
Inventor
John M. Padfield
Cheryl V. Groom
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of CA1203176A publication Critical patent/CA1203176A/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA000429095A 1982-05-27 1983-05-27 Produits pharmaceutiques Expired CA1203176A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8215502 1982-05-27
GB8215502 1982-05-27

Publications (1)

Publication Number Publication Date
CA1203176A true CA1203176A (fr) 1986-04-15

Family

ID=10530673

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000429095A Expired CA1203176A (fr) 1982-05-27 1983-05-27 Produits pharmaceutiques

Country Status (25)

Country Link
JP (1) JPH0629181B2 (fr)
AT (1) AT390191B (fr)
AU (1) AU567675B2 (fr)
BE (1) BE896870A (fr)
CA (1) CA1203176A (fr)
CH (1) CH656308A5 (fr)
DE (1) DE3319356C2 (fr)
DK (1) DK167558B1 (fr)
ES (1) ES8502336A1 (fr)
FI (1) FI81257C (fr)
FR (1) FR2527442B1 (fr)
GR (1) GR82681B (fr)
IE (1) IE55139B1 (fr)
IL (1) IL68805A0 (fr)
IT (1) IT1174759B (fr)
LU (1) LU84828A1 (fr)
MY (1) MY8700275A (fr)
NL (1) NL192663C (fr)
NO (1) NO163166C (fr)
NZ (1) NZ204385A (fr)
PH (1) PH19601A (fr)
PT (1) PT76773B (fr)
SE (1) SE454946B (fr)
ZA (1) ZA833854B (fr)
ZW (1) ZW11883A1 (fr)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3624213A (en) * 1963-10-30 1971-11-30 Merck & Co Inc Method of sterilizing aqueous pharmaceutical solutions employing propylene oxide and entrained air
GB1200886A (en) * 1966-09-23 1970-08-05 Allen & Hanburys Ltd Phenylaminoethanol derivatives
GB1453034A (en) * 1972-12-15 1976-10-20 Boehringer Sohn Ingelheim Pharmaceutical composition for treating spasticity
JPS5831210B2 (ja) * 1973-04-09 1983-07-05 武田薬品工業株式会社 アンテイナスイセイケンダクエキノセイゾウホウ
DE2714065A1 (de) * 1977-03-30 1978-10-12 Boehringer Mannheim Gmbh Instillationszubereitung

Also Published As

Publication number Publication date
JPS591411A (ja) 1984-01-06
SE8303012L (sv) 1983-11-28
FR2527442A1 (fr) 1983-12-02
ES522752A0 (es) 1985-01-01
ATA195283A (de) 1989-09-15
PT76773B (en) 1986-03-27
PH19601A (en) 1986-05-27
NL8301900A (nl) 1983-12-16
NO163166C (no) 1990-05-02
FI831893A0 (fi) 1983-05-27
AU1503983A (en) 1983-12-01
FI81257B (fi) 1990-06-29
FR2527442B1 (fr) 1987-07-17
IE55139B1 (en) 1990-06-06
LU84828A1 (fr) 1985-03-21
DE3319356C2 (de) 1996-07-04
PT76773A (en) 1983-06-01
IT8348384A0 (it) 1983-05-27
IT1174759B (it) 1987-07-01
AU567675B2 (en) 1987-12-03
FI831893L (fi) 1983-11-28
BE896870A (fr) 1983-11-28
NO831875L (no) 1983-11-28
NZ204385A (en) 1986-07-11
CH656308A5 (fr) 1986-06-30
NL192663B (fr) 1997-08-01
SE454946B (sv) 1988-06-13
DK241783D0 (da) 1983-05-27
IE831267L (en) 1983-11-27
GR82681B (fr) 1985-02-07
AT390191B (de) 1990-03-26
NL192663C (nl) 1997-12-02
ZA833854B (en) 1985-01-30
FI81257C (fi) 1990-10-10
ZW11883A1 (en) 1984-12-19
DK167558B1 (da) 1993-11-22
DE3319356A1 (de) 1983-12-01
SE8303012D0 (sv) 1983-05-27
MY8700275A (en) 1987-12-31
IL68805A0 (en) 1983-09-30
DK241783A (da) 1983-11-28
NO163166B (no) 1990-01-08
ES8502336A1 (es) 1985-01-01
JPH0629181B2 (ja) 1994-04-20

Similar Documents

Publication Publication Date Title
US5024997A (en) Palatable ibuprofen solutions
US4499108A (en) Stable pleasant-tasting albuterol sulfate pharmaceutical formulations
US20090048344A1 (en) Pharmaceutical composition comprising 5-methyl-2-2' (chloro-6'-fluoroanilino phe nylacetic acid
US5498426A (en) Liquid antacid compositions
CA2246501A1 (fr) Formulation d'hormone de croissance stabilisee et procede pour la preparer
US5182101A (en) Anti-plaque toothpaste
MXPA97002456A (en) Liquid antiacidal compositions containing calcium carbonate and possibly simeticone as active compounds and monobasic potassium phosphate and potassium bicarbonate as regula
JP2590156B2 (ja) 経口投与用医薬組成物
US4594359A (en) Pharmaceutical compositions
CA1326453C (fr) Composition pharmaceutique a base de pentamidine
JP2002179541A (ja) カチオン性殺菌剤を含む口腔用組成物
CA1203176A (fr) Produits pharmaceutiques
GB2120942A (en) Salbutamol compositions
EP0468232B1 (fr) Sirops ayant des propriétés de mise en suspension
WO2022064006A1 (fr) Composition d'hydroxyapatite pour le traitement et/ou la prévention d'une infection virale
JPH1029937A (ja) メフェナム酸水溶液製剤
JP3136421B2 (ja) セチルピリジニウムの安定剤
HUT63060A (en) Process for producing pharmaceutical compositions locally applicable on nose and eye, comprising bradykinin antagonists
US4666926A (en) Transdermal formulations
US5879711A (en) Stable antiandrogenic gel composition
JP2893807B2 (ja) アズレン誘導体含有液剤
JPH01313430A (ja) コクシジウム抑制剤の水溶性製剤
JPS6348211A (ja) アズレン系抗炎症剤
JPS647967B2 (fr)
JPS6023318A (ja) 点眼液

Legal Events

Date Code Title Description
MKEX Expiry